A Trial of CRD-4730 in HFrEF

NCT07750873 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: CRD-4730
DRUG: Placebo

Sponsor

Cardurion Pharmaceuticals, Inc.